Will autonomous agents uncover unexpected mechanisms or new target biology?

Determine whether autonomous AI research agents for biological discovery, such as Latent-Y, can uncover unexpected mechanisms of action or identify entirely new target biology beyond current knowledge in drug discovery.

Background

The paper demonstrates that Latent-Y, an autonomous agent integrated with the Latent Labs Platform and powered by the Latent-X2 generative model, can design de novo nanobody binders from text prompts and achieve lab-validated binding with nanomolar affinities. It also shows the agent’s ability to operate from literature context alone and to extend its own capabilities for cross-species design.

Despite these results, the authors highlight a broader unresolved question concerning the scope of autonomous scientific discovery: beyond producing novel molecules, it remains unsettled whether such agents can uncover unexpected mechanisms or entirely new target biology. This open question delineates the frontier between automated candidate generation and truly novel mechanistic or biological insight.